10:44 AM EST - Acerus Pharmaceuticals Corporation : Has received a Notice of Deficiency-Withdrawal Letter for its GynoflorTM New Drug Submission. The Company has 30 days to decide if it wishes to file a Letter of Intent to file a Request for Reconsideration of the Notice. Acerus Pharmaceuticals Corporation
shares T.ASP are trading down $0.0025 at $0.12.
